823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma

• Thomas Mace,
• Gregory B Lesinski,
• Chrystal M Paulos,
• Michael Ware,
• Olatunji Alese,
• Juan Sarmiento,
• Shishir Maithel,
• Maggie Phillips,
• Megan M Wyatt,
• Natalie K Horvat,
• Jacklyn Hammons,
• Bassel FEl Reyes

Affiliations

Thomas Mace

3The Ohio State University, Columbus, OH, USA

Gregory B Lesinski

Emory University, Atlanta, GA, USA

Chrystal M Paulos

Emory University, Atlanta, GA, USA

Michael Ware

2NeoImmuneTech, Inc., Snellville, GA, USA

Olatunji Alese

4Winship Cancer Institute at Emory University, Atlanta, GA, USA

Juan Sarmiento

1Emory University, Atlanta, GA, USA

Shishir Maithel

1Emory University, Atlanta, GA, USA

Maggie Phillips

1Emory University, Atlanta, GA, USA

Megan M Wyatt

Emory University, Atlanta, GA, USA

Natalie K Horvat

Emory University, Atlanta, GA, USA

Jacklyn Hammons

Emory University, Atlanta, GA, USA

Bassel FEl Reyes

5University of Alabama at Birmingham Medical Center, Birmingham, AL, USA